Mark Levin - Director, 10%+ Owner at Fulcrum Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Issuer Symbol
FULC on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Levin since 25 Feb 2025

Holdings reported by Mark Levin for Fulcrum Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3,962,202 $13,114,889 $3.31 10 Nov 2021 Indirect
Common Stock 75,800 $250,898 $3.31 10 Nov 2021 Direct

Transactions reported by Mark Levin for Fulcrum Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.